The trail-blazing development of new drugs, which could help revolutionise tuberculosis treatment and save millions of lives in South Africa and the rest of the world, was announced in Cape Town on Thursday.
Scientists attending the 38th Union Conference on lung health at the Cape Town International Convention Centre say two drugs with "incredible promise" are advancing in clinical trials in TB patients.
Dr Maria Freire, CEO and president of the Global Alliance for TB Drug Development (TB Alliance) described the research advances as "an historic milestone" in the accelerated drive to halt the catastrophic number of lives still lost through a disease which, when treated correctly, is curable.
For thousands of TB sufferers, many with drug-resistant strains, a new arsenal of drugs is the life-saver they have been hoping and praying for.
One of the drugs, known as PA-824, is the first novel TB drug, developed on a not-for-profit basis, to enter testing in TB patients... - IOL
Scientists attending the 38th Union Conference on lung health at the Cape Town International Convention Centre say two drugs with "incredible promise" are advancing in clinical trials in TB patients.
Dr Maria Freire, CEO and president of the Global Alliance for TB Drug Development (TB Alliance) described the research advances as "an historic milestone" in the accelerated drive to halt the catastrophic number of lives still lost through a disease which, when treated correctly, is curable.
For thousands of TB sufferers, many with drug-resistant strains, a new arsenal of drugs is the life-saver they have been hoping and praying for.
Said a Khayelitsha clinic sister: "To tell someone there are no other drugs left is heart-breaking. Now we are seeing some light. This is great news."
One of the drugs, known as PA-824, is the first novel TB drug, developed on a not-for-profit basis, to enter testing in TB patients... - IOL
No comments:
Post a Comment